Lemonade, Inc.
49.22USD
-1.3300 (-2.63%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.6▼ | $-0.52 | 2 | 8 |
| Next quarter | $-0.23▼ | $-0.17 | 2 | 6 |
| Current year | $-1.87▼ | $-1.73 | 1 | 10 |
| Next year | $-1.1▼ | $-0.81 | 0 | 10 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.56 | $-0.56 | +0.00 (+0.5%) |
| 2026-03-31 | $-0.57 | $-0.47 | +0.10 (+17.0%) |
| 2025-12-31 | $-0.39 | $-0.29 | +0.10 (+26.1%) |
| 2025-09-30 | $-0.7 | $-0.51 | +0.19 (+27.6%) |
102 ratings from 16 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Equal-Weight | $65 $56 | Aug 19, 2026 |
| Piper Sandler | Maintained | Neutral | $75 $51 | Jul 30, 2026 |
| Keefe, Bruyette & Woods | Upgraded from Underperform | Market Perform | $48 | Jul 30, 2026 |
| Piper Sandler | Maintained | Neutral | $62 $75 | Jul 15, 2026 |
| Keefe, Bruyette & Woods | Maintained | Underperform | $44 $48 | Jul 8, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $75 | Jul 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $80 $75 | May 21, 2026 |
| Piper Sandler | Maintained | Neutral | $65 $62 | Apr 30, 2026 |
| Citizens | Maintained | Market Outperform | $85 $80 | Apr 30, 2026 |
| Truist Securities | Maintained | Buy | $98 $70 | Apr 30, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $80 $85 | Mar 17, 2026 |
| Keefe, Bruyette & Woods | Maintained | Underperform | $40 $44 | Feb 24, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $85 $92 | Jan 14, 2026 |
| Truist Securities | Initiated | Buy | $98 | Jan 6, 2026 |
| Keefe, Bruyette & Woods | Maintained | Underperform | $35 $40 | Nov 25, 2025 |
| Citizens | Maintained | Market Outperform | $60 $80 | Nov 24, 2025 |
| Morgan Stanley | Maintained | Underweight | $49 $53 | Nov 17, 2025 |
| Morgan Stanley | Maintained | Underweight | $45 $49 | Nov 10, 2025 |
| Piper Sandler | Maintained | Neutral | $60 $55 | Oct 10, 2025 |
| Morgan Stanley | Maintained | Underweight | $43 $45 | Oct 7, 2025 |
| Piper Sandler | Maintained | Neutral | $55 $60 | Sep 17, 2025 |
| BMO Capital | Maintained | Underperform | $23 $42 | Aug 18, 2025 |
| Morgan Stanley | Maintained | Underweight | $24 $26 | Jul 14, 2025 |
| BMO Capital | Maintained | Underperform | $15 $23 | Jul 2, 2025 |
| Keefe, Bruyette & Woods | Reiterated | Underperform | $22 $26 | Jul 1, 2025 |
144 filings from 18 insiders · 14 buy / 9 sell over 6m
Officers and directors of LMND, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Peters John SheldonOfficer, Chief Insurance Officer | Sell | 2.2k | $54.45 | $122k | Sep 4, 2026 |
| Prosor MayaOfficer, Chief Business Officer | Sell | 1.0k | $54.63 | $57k | Sep 3, 2026 |
| Peters John SheldonOfficer, Chief Insurance Officer | Sell | 859 | $54.63 | $47k | Sep 3, 2026 |
| BIXBY TIMOTHY EOfficer, Chief Financial Officer | Sell | 1.9k | $54.63 | $103k | Sep 3, 2026 |
| Wininger ShaiDirector; Officer, President | Gift | 1.9k | — | — | Sep 2, 2026 |
| PETERS JOHN SHELDONOfficer | Sell | 11.0k | $52.55 | $578k | Aug 13, 2026 |
| PETERS JOHN SHELDONOfficer | Grant | 10.0k | — | — | Jul 27, 2026 |
| BIXBY TIMOTHY EChief Financial Officer | Sell | 73.0k | $79.18 | $5.78M | Jul 7, 2026 |
| PETERS JOHN SHELDONOfficer | Sell | 3.4k | $79.00 | $272k | Jul 6, 2026 |
| EISENBERG MICHAEL ADirector | Gift | 5.0k | — | — | Jun 10, 2026 |
| PETERS JOHN SHELDONOfficer | Sell | 5.3k | $52.94 | $283k | Jun 4, 2026 |
| BIXBY TIMOTHY EChief Financial Officer | Sell | 2.2k | $53.17 | $118k | Jun 3, 2026 |
| PROSOR MAYAOfficer | Sell | 1.2k | $53.17 | $65k | Jun 3, 2026 |
| SCHWARTZ DEBRADirector | Grant | 2.8k | — | — | Jun 3, 2026 |
| HAJ-YEHIA SAMERDirector | Grant | 2.8k | — | — | Jun 3, 2026 |
| ANGELIDIS SMITH MARIADirector | Grant | 2.8k | — | — | Jun 3, 2026 |
| SEELEY GEOFFDirector | Grant | 2.8k | — | — | Jun 3, 2026 |
| RATANCHANDANI PRASHANTDirector | Grant | 2.8k | — | — | Jun 3, 2026 |
| SCHREIBER DANIEL AChief Executive Officer | Grant | 1.00M | — | — | Mar 18, 2026 |
| WININGER SHAIPresident | Grant | 1.00M | — | — | Mar 18, 2026 |
No analyst notes on LMND yet.
Analyst Ratings
9 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 2 | 6 | 2 | 0 | Hold2.82 |
| 1 mo ago | 1 | 2 | 6 | 2 | 0 | Hold2.82 |
| 2 mo ago | 2 | 2 | 4 | 2 | 1 | Hold2.82 |